These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 28041951

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers.
    Brown SB, Hankinson SE.
    Steroids; 2015 Jul; 99(Pt A):8-10. PubMed ID: 25555473
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P, Daures JP, Thezenas S, Guilleux F, Rouanet P, Grenier J.
    Cancer; 1998 Aug 15; 83(4):698-705. PubMed ID: 9708933
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors.
    Wiebe JP, Zhang G, Welch I, Cadieux-Pitre HA.
    Breast Cancer Res; 2013 May 11; 15(3):R38. PubMed ID: 25927181
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK.
    Oncol Rep; 2007 Nov 11; 18(5):1051-9. PubMed ID: 17914554
    [Abstract] [Full Text] [Related]

  • 14. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
    Milewicz T, Gregoraszczuk EL, Sztefko K, Augustowska K, Krzysiek J, Ryś J.
    Growth Horm IGF Res; 2005 Apr 11; 15(2):140-7. PubMed ID: 15809018
    [Abstract] [Full Text] [Related]

  • 15. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 16. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M, Jukić S, Ilić-Forko J, Babić D, Uzarević B, Petrovecki M, Suchanek E, Skrablin S, Dotlić S, Marusić M.
    Gynecol Oncol; 1999 Mar 04; 72(3):331-6. PubMed ID: 10053103
    [Abstract] [Full Text] [Related]

  • 17. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV, Pike MC.
    Acta Oncol; 1992 Mar 04; 31(2):167-74. PubMed ID: 1622631
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.